🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsDosing & ProtocolsWhen to hold at a dose vs continue titrating — my results so far

When to hold at a dose vs continue titrating — my results so far

Dr.BariatricHTX Mon, Nov 11, 2024 at 8:05 PM 18 replies 1,996 viewsPage 1 of 4
This thread is more than 19 months old. Information may be outdated. Consider searching for more recent discussions.
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Nov 11, 2024 at 8:05 PM#1

I titrated faster than the label because I felt fine, hit a wall at the third step, and had to come back down — which I now think was the predictable outcome rather than bad luck.

The narrow version of the question is what the trials actually did with participants who could not tolerate a step, because that is the situation I am in and the protocol summaries skip it.

Not looking for reassurance. Looking for the part I have got wrong.

7 2CarlaRPh_TPA, steph_laguna, fiona_glasgow and 4 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Nov 11, 2024 at 8:37 PM#2

Answering the narrow version, because the broad one does not have a single answer. Holding longer is the underrated move. A step that is uncomfortable at week two is frequently comfortable at week six with no change in dose, because the gastric-emptying component tachyphylaxes while the appetite effect persists. Escalating at week two throws that adaptation away.

Last edited: Nov 12, 2024 at 12:37 AM
6 1ricardo_MIA, BrianDallas92, labquiet_amy and 3 others
Reply Quote Save Share Report
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Nov 11, 2024 at 9:09 PM#3
CarlaRPh_TPA said:
A step that is uncomfortable at week two is frequently comfortable at week six with no change in dose, because the gastric-emptying component…

Agreed on the arithmetic, with one condition: holding indefinitely at a dose that is not doing anything is not patience, it is a stall with a nice name. The distinction is whether appetite has changed at all at the current step.

5 0Dr.SleepRoch, laura_annarbor, JenMemphis and 2 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
Nov 11, 2024 at 9:41 PM#4
Dr.BariatricHTX said:
I titrated faster than the label because I felt fine, hit a wall at the third step, and had to come back down — which I now think was the predictable…

This matches mine closely enough to be worth saying so. The trials generally allowed a step to be held or reduced and then retried, and people who did that mostly arrived at the same place a few weeks later. The end point of the ladder is set by tolerability, not by a schedule, and there is no evidence that reaching the top faster produces a better outcome.

4 24mike.trainer_LA, sarah_nash92, FitDadDave and 1 other
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Nov 12, 2024 at 12:40 AM#5

Adding the clinical framing, because it changes how the question reads.

Dose escalation anxiety for titration: I was terrified to move from 0.5mg to 1.0mg based on horror stories in this forum. But my actual experience? Slightly more appetite suppression, zero additional side effects.

Remember that the people posting about terrible side effects are a biased sample. Most people titrate up without drama — they just don't post about it because it's uneventful.

3 23cory_ATX, lori_vegas, Dr.PulmRoch
Reply Quote Save Share Report

Similar Threads

Micro-dosing semaglutide — is sub-therapeutic dosing effective?16 replies
Injection technique: subcutaneous depot formation and absorption8 replies
Semaglutide PK modeling — when to time your injection12 replies
Reconstitution calculator — compounded peptide dosing math7 replies
Half-life implications for missed doses — PK-based guidance5 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register